Crinetics Pharmaceuticals In shares owned by Vanguard Group
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crinetics Pharmaceuticals In by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $382M | 9.2M | 41.65 |
| 2025-06-30 | $266M | 9.3M | 28.76 |
| 2025-03-31 | $312M | 9.3M | 33.54 |
| 2024-12-31 | $465M | 9.1M | 51.13 |
| 2024-09-30 | $321M | 6.3M | 51.10 |
| 2024-06-30 | $202M | 4.5M | 44.79 |
| 2024-03-31 | $167M | 3.6M | 46.81 |
| 2023-12-31 | $125M | 3.5M | 35.58 |
| 2023-09-30 | $101M | 3.4M | 29.74 |
| 2023-06-30 | $49M | 2.7M | 18.02 |
| 2023-03-31 | $43M | 2.7M | 16.06 |
| 2022-12-31 | $44M | 2.4M | 18.30 |
| 2022-06-30 | $46M | 2.4M | 18.65 |
| 2022-03-31 | $46M | 2.1M | 21.95 |
| 2021-09-30 | $35M | 1.7M | 21.05 |
| 2021-06-30 | $28M | 1.5M | 18.84 |
| 2021-03-31 | $18M | 1.2M | 15.27 |
| 2020-12-31 | $16M | 1.2M | 14.10 |
| 2020-09-30 | $17M | 1.1M | 15.67 |
| 2020-06-30 | $19M | 1.1M | 17.53 |
| 2020-03-31 | $7.5M | 508k | 14.70 |
| 2019-12-31 | $13M | 504k | 25.09 |
| 2019-09-30 | $7.7M | 504k | 15.19 |
| 2019-03-31 | $10M | 452k | 22.74 |
| 2018-12-31 | $8.2M | 273k | 29.96 |
| 2018-09-30 | $7.1M | 248k | 28.67 |